Stay updated on Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s footer revision label is updated from **v3.5.2** to **v3.5.3**, indicating a site software/version refresh rather than a change to the clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-24T06:02:01.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:56.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T04:49:43.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Page revision updated to v3.4.3, replacing v3.4.2. No changes to study details or content are visible.
    Difference
    0.1%
    Check dated 2026-03-12T00:25:05.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page shows Revision: v3.4.2 and a funding/status notice was removed. These are administrative updates that do not affect study data, eligibility criteria, outcomes, or how users interact with the page.
    Difference
    0.4%
    Check dated 2026-02-11T11:17:19.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Notice about government funding and NIH Clinical Center status added. Site revision updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T06:37:15.000Z thumbnail image

Stay in the know with updates to Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.